Olfert Landt (TIB Molbiol Syntheselabor GmbH)

Landt, Olfert (GenExpress GmbH 201102 Managing Director + TIB Molbiol 200312–2009– Managing Director)

	Organisation	TIB Molbiol Syntheselabor GmbH
	Group	TIB Molbiol (Group)
	Former/major organisation	GenExpress Gesellschaft für Proteindesign mbH
	Product	oligo synthesis
	Product 2	Aliquator 480

Record changed: 2021-09-15

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Olfert Landt

[1] Roche. (9/9/21). "Press Release: Roche Signs Definitive Share Purchase Agreement with Long-Term Partner TIB Molbiol to Expand PCR-test Portfolio in the Fight against New Infectious Diseases". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)